Laeyendecker Oliver, Henson Charla, Gray Ronald H, Nguyen Ruby H-N, Horne Bobbi Jo, Wawer Maria J, Serwadda David, Kiwanuka Noah, Morrow Rhoda Ashley, Hogrefe Wayne, Quinn Thomas C
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
J Clin Microbiol. 2004 Apr;42(4):1794-6. doi: 10.1128/JCM.42.4.1794-1796.2004.
Two hundred forty-eight human immunodeficiency virus (HIV)-positive and 496 HIV-negative subjects in Uganda were tested by HerpeSelect herpes simplex virus type 2 enzyme-linked immunosorbent assay (ELISA) and Western blotting to optimize the ELISA for use in this population. A higher index cutoff value was required for optimal sensitivity and specificity, and overall performance of the assay was not affected by HIV status.
在乌干达,对248名人类免疫缺陷病毒(HIV)阳性和496名HIV阴性受试者进行了HerpeSelect 2型单纯疱疹病毒酶联免疫吸附测定(ELISA)和蛋白质印迹法检测,以优化该ELISA在这一人群中的应用。为实现最佳敏感性和特异性,需要更高的指数临界值,并且该检测的总体性能不受HIV感染状况的影响。